Sample cohort | M/F | Age* | Fibrosis stage* |
|---|
Control+ | 3/1 | 61.2āĀ±ā16.6 | 0āĀ±ā0 |
ALD | 10/4 | 53.4āĀ±ā10.4 | 3.6āĀ±ā0.5 |
NAFLD/NASH | 3/5 | 58.1āĀ±ā11.6 | 3.6āĀ±ā0.5 |
HCV | 7/3 | 56.9āĀ±ā6.5 | 4āĀ±ā0 |
Other etiologies# | 2/6 | 52.4āĀ±ā15.8 | 4āĀ±ā0 |
- ALD alcoholic liver disease, HCV chronic hepatitis C infection, NAFLD non-alcoholic fatty liver disease, NASH non-alcoholic steatohepatitis
- #Other etiologies include one patient with chronic hepatitis B and ALD, one with autoimmune hepatitis, one with cryptogenic cirrhosis, and one with biliary cirrhosis
- +Control samples were used for western blotting and staining
- *Data are expressed as meanāĀ±āSD
